Additionally, in a second assessment, we focused on molecular imaging responders after two courses of 177Lu-PSMA-617 (n = 25), a subgroup in whom tumor sink effects would perhaps be likeliest to manifest. This evidence concerns the gene FOLH1 and neoplasm.